Table of Contents

August 01, 2021; Volume 18,Issue 3

  1. Andrushkevich, Oleg M.

    1. Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511

  2. Angelini, Daniela F.

    1. CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
      Rosaria A. Fontanella, Silvia Sideri, Chiara Di Stefano, Angiolina Catizone, Silvia Di Agostino, Daniela F. Angelini, Gisella Guerrera, Luca Battistini, Giulia Battafarano, Andrea Del Fattore, Antonio Francesco Campese, Fabrizio Padula, Paola De Cesaris, Antonio Filippini and Anna Riccioli
      Cancer Biology & Medicine August 2021, 18 (3) 788-807; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0495

  3. Bai, Yuting

    1. Transcription factor-based gene therapy to treat glioblastoma through direct neuronal conversion
      Xin Wang, Zifei Pei, Aasma Hossain, Yuting Bai and Gong Chen
      Cancer Biology & Medicine August 2021, 18 (3) 860-874; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0499

  4. Bai, Zixuan

    1. VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer in vivo
      Guangbo Kang, Min Hu, He Ren, Jiewen Wang, Xin Cheng, Ruowei Li, Bo Yuan, Yasmine Balan, Zixuan Bai and He Huang
      Cancer Biology & Medicine August 2021, 18 (3) 772-787; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0568

  5. Balan, Yasmine

    1. VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer in vivo
      Guangbo Kang, Min Hu, He Ren, Jiewen Wang, Xin Cheng, Ruowei Li, Bo Yuan, Yasmine Balan, Zixuan Bai and He Huang
      Cancer Biology & Medicine August 2021, 18 (3) 772-787; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0568

  6. Balthasar, Joseph P.

    1. Strategies to enhance monoclonal antibody uptake and distribution in solid tumors
      Brandon M. Bordeau and Joseph P. Balthasar
      Cancer Biology & Medicine August 2021, 18 (3) 649-664; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0704

  7. Battafarano, Giulia

    1. CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
      Rosaria A. Fontanella, Silvia Sideri, Chiara Di Stefano, Angiolina Catizone, Silvia Di Agostino, Daniela F. Angelini, Gisella Guerrera, Luca Battistini, Giulia Battafarano, Andrea Del Fattore, Antonio Francesco Campese, Fabrizio Padula, Paola De Cesaris, Antonio Filippini and Anna Riccioli
      Cancer Biology & Medicine August 2021, 18 (3) 788-807; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0495

  8. Battistini, Luca

    1. CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
      Rosaria A. Fontanella, Silvia Sideri, Chiara Di Stefano, Angiolina Catizone, Silvia Di Agostino, Daniela F. Angelini, Gisella Guerrera, Luca Battistini, Giulia Battafarano, Andrea Del Fattore, Antonio Francesco Campese, Fabrizio Padula, Paola De Cesaris, Antonio Filippini and Anna Riccioli
      Cancer Biology & Medicine August 2021, 18 (3) 788-807; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0495

  9. Bervitskiy, Anatoliy V.

    1. Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511

  10. Bi, Minghong

    1. Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
      Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li and Baohui Han
      Cancer Biology & Medicine August 2021, 18 (3) 816-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0212
« Previous (Pages : 1 2 3 4 5 6 ... 28) Next »
Back to top

In this issue

Cancer Biology and Medicine: 18 (3)
Cancer Biology & Medicine
Vol. 18, Issue 3
1 Aug 2021

Submit

Sign up for alerts